Document Detail

Review of the status of intermittent positive pressure breathing therapy.
MedLine Citation:
PMID:  6439542     Owner:  NLM     Status:  MEDLINE    
With the advent of diagnosis related groups reimbursement schedules, the cost-effectiveness of therapies needs to be assessed. The safety and efficacy of intermittent positive pressure breathing (IPPB) has been controversial. IPPB employs the dilating effects of positive-pressure ventilation to deliver aerosolized particles to small and medium-sized bronchi of patients with obstructive airways disease. IPPB is expensive to implement and maintain. The hazards of IPPB (infection, pneumothorax, decreased cardiac output), although rare, could prolong hospital stays. Except for severely ill patients with fatigued respiratory muscles, IPPB offers no advantages over the less costly and safer compressor-nebulizer or metered-dose delivery of a beta-agonist.
E R Gonzalez; T G Burke
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug intelligence & clinical pharmacy     Volume:  18     ISSN:  0012-6578     ISO Abbreviation:  Drug Intell Clin Pharm     Publication Date:  1984 Dec 
Date Detail:
Created Date:  1985-02-14     Completed Date:  1985-02-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0212457     Medline TA:  Drug Intell Clin Pharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  974-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Asthma / physiopathology
Diagnosis-Related Groups
Forced Expiratory Volume
Intermittent Positive-Pressure Breathing* / adverse effects,  economics
Lung Diseases, Obstructive / therapy*
Positive-Pressure Respiration* / adverse effects,  economics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bupropion hydrochloride.
Next Document:  A comparison of standardized methods for measuring the biological activity of pesticides to the eart...